|  | Crude model | Adjusted model | ||
---|---|---|---|---|---|
Variable | Events/N (%) or Median (IQR) | OR (95% CI) | P-value | OR (95% CI) | P-value |
Case management | |||||
 No case management | 60/1549 (3.9) | Reference |  |  |  |
 With case management | 31/3357 (0.9) | 0.23 (0.15–0.36) | < 0.001 | 0.27 (0.17–0.42) | < 0.001 |
WHO Clinical stage | |||||
 Stage I and stage II | 69/4368 (1.6) | Reference |  | Reference |  |
 Stage III and stage IV | 22 /538 (4.1) | 2.67 (1.63–4.33) | < 0.001 | 1.94 (1.17–3.21) | 0.010 |
CD4 cell counts | |||||
  < 500 | 83/4229 (2.0) | Reference |  | Reference |  |
 500+ | 8/677 (1.2) | 0.60 (0.29–1.24) | 0.167 | 0.89 (0.42–1.87) | 0.756 |